—

Pharmazz, Inc.

Phase 3 Estimated

Sovateltide

Acute Ischemic Stroke

Countdown

86days

Phase 3 readout · ~ Sep 30, 2026 estimated

What's at stake Phase 3 trial results for Sovateltide in Acute Ischemic Stroke are due ~ Sep 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · ClinicalTrials.gov verified 13h ago

“CT.gov NCT05691244: Phase 3 trial, sponsor Pharmazz, Inc., drug Sovateltide. Primary completion date 2026-09 (estimated).”

Add to calendar Post on X Reddit

Provenance